Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TJC, formerly known as The Jordan Company, is a leading middle-market private equity firm headquartered in New York with over $28 billion in assets under management. Founded in 1982, the firm has established a significant presence in the healthcare and life sciences sectors by investing in market-leading service and technology providers. TJC's healthcare strategy focuses on mission-critical businesses that support clinical research, regulatory compliance, and specialized medical manufacturing. Notable healthcare portfolio companies include Advarra, a premier provider of IRB and compliance services, and ArisGlobal, a leader in drug safety and pharmacovigilance software. The firm is recognized for its long-term investment horizon and its collaborative Partnership Program approach with management teams.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Jordan Company.